Abbott Laboratories (NYSE:ABT) is one of the top low volatility healthcare stocks to buy now. Analyst Mike Kratky from ...

Abbott Laboratories (NYSE:ABT) ranks among the best low volatility stocks to buy according to analysts. RBC Capital ...

Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Abbott Laboratories (NYSE:ABT) stock drops as the company reported mixed Q2 2025 results and sets its Q3 guidance below ...

Abbott Laboratories' second-largest division, diagnostics, continues to be a hindrance, while the FY group operating margin ...

Tracking Abbott Laboratories's Stock Performance Shares of Abbott Laboratories were trading at $116.7 as of October 14. Over the last 52-week period, shares are up 22.48%.

Importantly, Abbott Laboratories (NYSE:ABT) does carry debt. But the real question is whether this debt is making the company risky. Debt assists a business until the business has trouble paying it ...

Unfortunately, Abbott Laboratories stock offers a 1.8% yield at recent prices. That's only slightly better than the average dividend-paying stock in the benchmark S&P 500 index.

On the same day that United Airlines forecast stability, Abbott Labs warned investors to expect a $200 million hit.

AFP via Getty Images Abbott Laboratories reported $1 billion in fourth quarter profits despite an “expected year-over-year decline in Covid-19 testing-related sales,” the company said Wednesday.